406432
Last Update Posted: 2017-09-29
Recruiting has ended
All Genders accepted | 19 Years-45 Years |
12 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects
The study was designed to assess the steady-state pharmacokinetic profile of paroxetine after 14 day repeated daily dosing of the controlled release tablet formulation (25 mg) in healthy Chinese subjects.
Eligibility
Relevant conditions:
Depressive Disorder
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov